Most Innovative in 2012
We've been named to Fast Company's list of "The World's 50 Most Innovative Companies" list for making targeted, genetics-based cancer therapies.
Patient Perspectives: A Second Chance
Martin and Stacy discuss how receiving an organ transplant changed their lives.
Our immunology program offers the experience needed to transform knowledge into practice
Roles of the HER2 Family Medicines
Learn about three personalized Genentech medicines in the HER2 Family
A look at our approvals past and present.
Understanding Antibody-Drug Conjugates
ADCs combine three components to provide a unique treatment option.
Medical Information for HCPs
This convenient resource offers scientific and clinical information for US healthcare providers.
Help Your Patients
Genentech Access Solutions offers your patients coverage support, assistance, other useful information.
Living with Rheumatoid Arthritis
Brenda and Elaine discuss their diagnosis and the impact of chronic disease on their daily lives.
Bob Swanson & Herb Boyer started the company that launched an industry.
Information reimbursement denials and appeals as well as billing and coding.
A Patient-centric Approach
In this video short, you will get some touching insight into how Genentech works hand in hand with advocacy groups to make patients’ lives better and longer.
Call for Grants
Genentech is actively seeking applications for Independent Research Projects.
This video series explores ongoing research by our scientists in a variety of focus areas. Watch it on YouTube.
How to Get Into the Brain
Learn how Genentech scientists developed a new way to get medicines through the blood-brain barrier.
Support for Independent Medical Education
We support grants for independent medical education to further the advance of medicine and healthcare.